Dianthus Therapeutics, Inc. (DNTH) Holders & Ownership

Dianthus Therapeutics, Inc. (DNTH) ownership: Entities affiliated with Wellington Management Group LLP 8% · institutions 113% (13F 2026-03-31). Insider activity, 90 days: Routine (27 sales, 0 open-market buys). SEC EDGAR first-party data.

Top Institutional Holders (13F, rolled up by parent)

Source: SEC Form 13F
HolderSharesMarket Value% OutstandingReported
FMR (Fidelity)7767686.00$651.86M13.9%2026-03-31
BlackRock3175703.00$266.50M5.7%2026-03-31
Vanguard2679684.00$224.88M4.8%2026-03-31
RA Capital Management, L.P.2611733.00$219.18M4.7%2026-03-31
Wellington Management2595783.00$217.84M4.6%2026-03-31
Fairmount Funds Management LLC2537191.00$212.92M4.5%2026-03-31
Avidity Partners Management LP2104184.00$176.58M3.8%2026-03-31
Octagon Capital Advisors LP1946667.00$163.36M3.5%2026-03-31

Insider Trading Activity (Form 4)

Source: SEC Form 4
InsiderTransactionValueDate
Sellnull2026-08-19
Sellnull2026-08-19
Sellnull2026-08-19
Sellnull2026-08-13
Sellnull2026-08-13
Sellnull2026-08-10
Sellnull2026-08-10
Sellnull2026-08-10

Back to DNTH overview · DNTH earnings · All congressional trades

Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.